Compare AURA & LAES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AURA | LAES |
|---|---|---|
| Founded | 2007 | 2022 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 396.8M | 366.0M |
| IPO Year | 2021 | N/A |
| Metric | AURA | LAES |
|---|---|---|
| Price | $5.28 | $4.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $20.20 | $6.50 |
| AVG Volume (30 Days) | 178.6K | ★ 9.2M |
| Earning Date | 11-13-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $10,978,000.00 |
| Revenue This Year | N/A | $66.73 |
| Revenue Next Year | N/A | $92.76 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.35 | $1.99 |
| 52 Week High | $8.60 | $9.50 |
| Indicator | AURA | LAES |
|---|---|---|
| Relative Strength Index (RSI) | 32.59 | 48.21 |
| Support Level | $5.30 | $3.71 |
| Resistance Level | $6.34 | $4.76 |
| Average True Range (ATR) | 0.36 | 0.32 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 5.00 | 50.00 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.